Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 11—November 2010

Letter

Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir

Liviana Da DaltComments to Author , Arianna Calistri, Chiara Chillemi, Riccardo Cusinato, Elisa Franchin, Cristiano Salata, Dino Sgarabotto, Giuseppe Toscano, Antonio Gambino, and Giorgio Palù
Author affiliations: University of Padova, Padova, Italy (L. Da Dalt, A. Calistri, C. Chillemi, E. Franchin, C. Salata, G. Palù); and; Azienda Ospedaliera di Padova, Padova (R. Cusinato, E. Franchin, D. Sgarabotto, G. Toscano, A. Gambino)

Main Article

Figure

Schematic showing events surrounding oseltamivir-resistant pandemic (H1N1) 2009 virus infection in 3-year-old immunocrompromised child, Italy, in relation to viremia levels, expressed as relative units of influenza A RNA, normalized with respect to the housekeeping gene RNaseP.

Figure. Schematic showing events surrounding oseltamivir-resistant pandemic (H1N1) 2009 virus infection in 3-year-old immunocrompromised child, Italy, in relation to viremia levels, expressed as relative units of influenza A RNA, normalized with respect to the housekeeping gene RNaseP.

Main Article

TOP